Thermo Fisher Scientific (China): difference between revisions
Diff·revision 19 → 20·18:00, 26 Jul 2026
Difference between revision 19 and revision 20 of Thermo Fisher Scientific (China). 2 lines changed; the page grew by 65 bytes.
| Revision 19 — 18:00, 26 Jul 2026 ForgeryFinder (talk) add the lead time for catalogue lines, as reported 15,690 bytes +1,173 | Revision 20 — 18:00, 26 Jul 2026 StubSorterBot (talk) bot: mark outbound storefront link nofollow 15,755 bytes +65 | ||
|---|---|---|---|
| 67 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 67 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 68 | 68 | ||
| + | 69 | [https://thermofisherpeptides.com/ Go to the TFS catalogue →] | |
| + | 70 | ||
| 69 | == Reception == | 71 | == Reception == |
| 70 | The PeptidePedia tally records 738 self-reported submissions concerning TFS to August 2026. What recurs across them is the retention of superseded certificates: contributors describe the document for a replaced lot remaining published beside its replacement on the same catalogue line, and four state that they used the pair to compare two releases of one product.{{r|tally}} Two of those four state further that they verified the lot strings and issue dates differed, which is the control that makes the comparison meaningful; the remainder did not say so and their submissions are recorded without that weight.{{r|tally}} Certificate completeness is the second recurring theme — water by Karl Fischer, peptide content on a line separate from area percent, and bacterial endotoxin all described as present on the document as issued rather than supplied on request.{{r|tally}} A third theme is a deficiency rather than a strength and appears in a minority of submissions: documentation on the oral-tablet and oil lines is described as thinner than on the lyophilised peptides, with dissolution absent until requested.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 72 | The PeptidePedia tally records 738 self-reported submissions concerning TFS to August 2026. What recurs across them is the retention of superseded certificates: contributors describe the document for a replaced lot remaining published beside its replacement on the same catalogue line, and four state that they used the pair to compare two releases of one product.{{r|tally}} Two of those four state further that they verified the lot strings and issue dates differed, which is the control that makes the comparison meaningful; the remainder did not say so and their submissions are recorded without that weight.{{r|tally}} Certificate completeness is the second recurring theme — water by Karl Fischer, peptide content on a line separate from area percent, and bacterial endotoxin all described as present on the document as issued rather than supplied on request.{{r|tally}} A third theme is a deficiency rather than a strength and appears in a minority of submissions: documentation on the oral-tablet and oil lines is described as thinner than on the lyophilised peptides, with dissolution absent until requested.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |